Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies

Maurizio Callari; Matteo Dugo; Marco Barreca; Balazs Gyorffy; Barbara Galbardi; Lucia Viganò; Alberta Locatelli; Chiara Dall’Ara; Marina Ferrarini; Giancarlo Bisagni; Marco Colleoni; Mauro Mansutti; Claudio Zamagni; Lucia Del Mastro; Stefania Zambelli; Antonio Frassoldati; Olivia Biasi; Lajos Pusztai; Pinuccia Valagussa; Giuseppe Viale; Luca Gianni; Giampaolo Bianchini

doi:10.1038/s41467-025-57293-9

Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies

M Maurizio Callari M Matteo Dugo M Marco Barreca B Balazs Gyorffy B Barbara Galbardi L Lucia Viganò A Alberta Locatelli C Chiara Dall’Ara M Marina Ferrarini G Giancarlo Bisagni M Marco Colleoni M Mauro Mansutti C Claudio Zamagni (IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy) L Lucia Del Mastro S Stefania Zambelli A Antonio Frassoldati O Olivia Biasi L Lajos Pusztai P Pinuccia Valagussa G Giuseppe Viale L Luca Gianni (Fondazione Michelangelo Onlus, Milan) G Giampaolo Bianchini (IRCCS Ospedale San Raffaele, Milan)

Download PDF View Original

APA MLA Chicago BibTeX RIS

Article Details

Journal Nature Communications

Volume / Issue Vol. 16, Issue 1

Published March 04, 2025

DOI 10.1038/s41467-025-57293-9

ISSN 2041-1723

Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (22)

M

Maurizio Callari

M

Matteo Dugo

M

Marco Barreca

B

Balazs Gyorffy

B

Barbara Galbardi

L

Lucia Viganò

A

Alberta Locatelli

C

Chiara Dall’Ara

M

Marina Ferrarini

G

Giancarlo Bisagni

M

Marco Colleoni

M

Mauro Mansutti

C

Claudio Zamagni

IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy

L

Lucia Del Mastro

S

Stefania Zambelli

A

Antonio Frassoldati

O

Olivia Biasi

L

Lajos Pusztai

P

Pinuccia Valagussa

G

Giuseppe Viale

L

Luca Gianni

Fondazione Michelangelo Onlus, Milan

G

Giampaolo Bianchini

IRCCS Ospedale San Raffaele, Milan

Determinants of response and molecular dynamics in HER2+ER+ breast cancers from the NA-PHER2 trial receiving HER2-targeted and endocrine therapies

Article Details

Journal Info

Authors (22)

Related Articles from this Journal

Synthesis of adaptive 15N-nitrosyl-Co7 nanocluster for electrocatalytic C–H functionalization

Pan-Ebolavirus nanoparticle vaccine provides protection in rodents from lethal infection by Zaire and Sudan viruses

Multi-population GWAS meta-analysis identifies bladder cancer susceptibility loci and highlights genetic regulation of smoking-related risk

Genome-wide annotation of human multi-nucleotide variants reveals widespread functional differences from single nucleotide variants

Allele-specific chromatin architecture shapes imprinted domains and coordinates a distal enhancer and antisense transcription at the mouse Mest-Copg2 domain